Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
01/2015
01/13/2015US8933065 N-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
12/2014
12/25/2014US20140377247 Benzamides and related inhibitors of factor xa
11/2014
11/27/2014US20140350009 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
11/25/2014US8895781 Transition metal-catalyzed C—H amination using unactivated amines
09/2014
09/24/2014EP2780336A1 Structural variants of mycolactones for use in modulating inflammation, immunity and pain
08/2014
08/12/2014US8802701 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
08/07/2014US20140221405 Platelet adp receptor inhibitors
07/2014
07/23/2014CN101945872B 作为mch拮抗剂的(1-吖嗪酮)-取代的吡啶并吲哚 As mch antagonist (1-azine-one) - substituted pyrido-indole
07/03/2014US20140187772 Pyrazole compounds useful as protein kinase inhibitors
06/2014
06/17/2014US8754233 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
05/2014
05/21/2014EP1318140B9 Novel amide derivatives and medicinal use thereof
04/2014
04/23/2014EP2721037A1 Synthesis of hetero ionic compounds using dialkylcarbonate quaternization
04/15/2014US8697698 Pyrazole compounds useful as protein kinase inhibitors
04/08/2014US8691847 Benzamides and related inhibitors of factor Xa
02/2014
02/11/2014US8647780 Materials useful as electrolytic solutes
01/2014
01/29/2014CN103547584A Synthesis of hetero ionic compounds using dialkylcarbonate quaternization
01/21/2014US8633210 Triazole compounds useful as protein kinase inhibitors
12/2013
12/26/2013US20130345180 2,4- diaminopyrimidine derivatives
12/17/2013CA2651769C Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
11/2013
11/28/2013US20130316248 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
10/2013
10/31/2013WO2002064559A3 Thrombin inhibitors
10/31/2013DE59209330C5 Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Benzimidazoles, pharmaceutical compositions containing them and methods for their preparation
10/24/2013WO2002094883A3 One-step process for the preparation of halide-free hydrophobic salts
10/15/2013CA2731273C Processes and intermediates for preparing retroviral protease inhibitors
09/2013
09/12/2013US20130237572 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
09/03/2013US8524721 Platelet ADP receptor inhibitors
09/03/2013US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors
08/2013
08/27/2013US8518977 Benzamides and related inhibitors of factor XA
08/20/2013US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
08/01/2013US20130196987 Macrocyclic compounds useful as pharmaceuticals
07/2013
07/23/2013US8492560 Quinazoline derivatives as angiogenesis inhibitors
07/04/2013US20130172310 Benzamides and related inhibitors of factor xa
06/2013
06/13/2013DE102008041491B4 Verfahren zur Herstellung einer farblosen ionischen Flüssigkeit A process for producing a colorless ionic liquid
06/06/2013DE19907945B4 Herstellung von sterisch gehinderten Aminethern Preparation of sterically hindered amine ethers
05/2013
05/23/2013WO2013072896A1 Structural variants of mycolactones for use in modulating inflammation, immunity and pain
05/22/2013EP2594561A1 Structural variants of mycolactones for use in modulating inflammation, immunity and pain
05/15/2013CN1863891B Organic compound and organic light emitting device using the same
04/2013
04/30/2013US8431589 2,4-diaminopyrimidine derivatives
04/18/2013US20130096128 Pyrazole compounds useful as protein kinase inhibitors
04/18/2013DE102011054477A1 Verfahren zur katalytischen Heteroaromatenhydrierung Process for the catalytic Heteroaromatenhydrierung
04/16/2013US8420630 Pyrimidine derivatives
04/16/2013CA2643170C Sterically hindered amine ethers as stabilizers against light, oxygen and/or heat
04/04/2013US20130085159 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
04/03/2013CN101979394B A method to inhibit ethylene responses in plants
04/02/2013US8410272 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
03/2013
03/26/2013US8404690 Piperazine-2-carboxamide derivatives
02/2013
02/28/2013US20130053417 Cetp activity inhibitors
02/28/2013DE19964603B4 Sterisch gehinderte Aminether und deren Verwendung als Stabilisatoren für organisches Material Sterically hindered amine ethers and their use as stabilizers for organic material
01/2013
01/09/2013CN101798298B Imidazole derivatives
01/08/2013CA2478065C Macrocyclic compounds useful as pharmaceuticals
01/02/2013CN101830889B 嘧啶衍生物 Pyrimidine derivatives
12/2012
12/20/2012WO2012174564A1 Synthesis of hetero ionic compounds using dialkylcarbonate quaternization
12/20/2012CA2835225A1 Synthesis of hetero ionic compounds using dialkylcarbonate quaternization
12/11/2012US8329742 Macrocyclic compounds useful as pharmaceuticals
11/2012
11/28/2012CN101899039B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/27/2012CA2680292C Intermediates useful for the preparation of n-substituted carbamoyloxyalkyl-azolium derivatives
11/21/2012CN1474803B Novel amide derivatives and medicinal use thereof
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
10/2012
10/18/2012US20120263706 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
10/16/2012US8288425 Benzimidazoles
10/09/2012CA2674803C Quinazoline derivatives as angiogenesis inhibitors
09/2012
09/11/2012CA2445159C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
08/2012
08/21/2012US8247413 e.g. N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; opioid receptor inhibitor; analgesic, antiinflammatory agent; inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity
08/14/2012US8242115 Materials and methods to potentiate cancer treatment
08/07/2012US8236965 Benzimidazole derivatives and their use as a medicament
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
07/2012
07/25/2012CN101448844B Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
07/18/2012EP2476680A1 (1-Azinone)-Substituted Pyridoindoles
07/17/2012CA2492964C Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
07/17/2012CA2469187C Cis-2,4,5-triphenyl-imidazolines and their use in the treatment of tumors
07/05/2012US20120172364 Rate-controlled particles
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012CN101898982B Npy y5 antagonists
06/2012
06/27/2012CN101333196B 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/14/2012US20120149688 Platelet adp receptor inhibitors
06/12/2012US8198454 Amide derivatives and medicinal use thereof
06/06/2012CN1545508B 1,2,4-trioxolane antimalarials
06/05/2012CA2540163C Thrombin receptor antagonists
05/2012
05/24/2012US20120129887 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
05/17/2012US20120122908 Novel C-4 Substituted Retinoids
05/16/2012CN1854128B Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
05/15/2012CA2482657C Process for the preparation of monohydroperfluoroalkanes, bis(perfluoroalkyl)phosphinates and perfluoroalkylphosphonates
05/09/2012EP1501467B1 Heterocyclo inhibitors of potassium channel function
05/02/2012EP1399158B1 Non-therapeutic method of suppressing oestrus in mammalian non-human animal
05/01/2012CA2509226C Ionic liquids having [n(cf3)2]- anions
04/2012
04/25/2012CN101841005B New organic compound and organic light emitting device using the same
04/17/2012CA2427844C Naphthalene derivatives
04/05/2012US20120083602 Benzamides and related inhibitors of factor xa
03/2012
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/20/2012CA2493225C Quinoline derivatives and their use as mycobacterial inhibitors
03/20/2012CA2396227C 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
03/06/2012CA2498754C Benzimidazolones and their use as cytokine inhibitors
02/2012
02/29/2012EP1542997B1 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
02/28/2012US8124638 Tricyclic compounds useful as angiotensin II agonists
02/14/2012US8115027 NPY Y5 antagonist
02/07/2012CA2471044C Benzimidazole derivatives and their use as gnrh antagonists
02/02/2012US20120029192 Pyrazole Derivatives
02/01/2012CN102336716A 嘧啶衍生物 Pyrimidine derivatives
01/2012
01/31/2012CA2463989C Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
01/11/2012CN1914181B Method for producing ionic liquids
1 2 3 4 5 6 7 8 9 10 11 ... 163